CRO BioPharma Services completes 3 FDA inspections

By Melissa Fassbender contact

- Last updated on GMT

BioPharma Services has facilities in the US and Canada with a total bed capacity of 250. (Image: iStock/BrianAJackson)
BioPharma Services has facilities in the US and Canada with a total bed capacity of 250. (Image: iStock/BrianAJackson)

Related tags: Contract research organization, Food and drug administration, Fda

The Canada-based contract research organization (CRO) has successfully completed three US FDA inspections this month.

The inspections were routine and not prompted by a specific concern, Anna Taylor, VP business development, BioPharma Services, told Outsourcing-Pharma.com.

Each three inspections were separate and un-related​,” she said, adding that no observations or 483s were noted during any of the inspections.

The inspections were conducted over a span of two weeks and focused on nine studies, including four bioanalytical validations conducted in support of ANDA and NDA filings.

Following the close of each audit, the FDA left satisfied with our processes and procedures in Columbia, Missouri and Toronto, Canada​,” Taylor said.

Our last FDA inspections were in Nov 2015 with zero observations, as well. We are extremely pleased with our regulatory track record​.”

BioPharma Services Inc. is a full-service contract research organization (CRO) specializing in Phase I/IIa clinical trials as well as bioequivalence trials. 

Related news

Related products

show more

Stability Testing As a Quality Control Measure

Stability Testing As a Quality Control Measure

Frontage Laboratories | 19-Jun-2019 | Technical / White Paper

Stability testing is, in essence, a quality control process and is there¬fore a vital component of every phase of clinical development for both large and...

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Baxter BioPharma Solutions | 05-Nov-2018 | Technical / White Paper

Recent market reports suggest increasing product niches, which may lead to decreasing numbers of units per product, making dedicated facilities less practical....

Baxter’s Oncology Contract Manufacturing

Baxter’s Oncology Contract Manufacturing

Baxter BioPharma Solutions | 29-Aug-2018 | Product Brochure

Baxter BioPharma Solutions’ FOYA award-winning facility in Halle/Westfalen, Germany, offers state-of-the-art parenteral cGMP manufacturing at one location,...

Related suppliers

Follow us

Products

View more

Webinars